Nektar Therapeutics Announces Second Quarter 2026 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/4/2026

1. ZS
2. LULU
3. IOT
4. SPY
5. PATH
6. DOCU
7. ASAN
8. CIEN
9. GWRE
10. CPB

Go back to Nektar Therapeutics Announces Second Quarter 2026 Financial Results
Nektar Therapeutics (NASDAQ: NKTR) Delayed: 74.06 -2.31 (3.02%)
Previous Close $76.37    52 Week High $19.98 
Open $74.67    52 Week Low $10.52 
Day High $75.63    P/E N/A 
Day Low $73.64    EPS $-1.45 
Volume 191,453